DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

company name or ticker

3 Biotechs Investors Should Watch

The healthcare version of Where the Money Is.

Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5% - Tale of the Tape

A Deeper Look At Belviq And Phentermine - Why Investors Need To Model Expectations

Arena Pharmaceuticals (ARNA) Flagged As Strong On High Volume

It Takes Less Than 15 Minutes To Buy VVUS Shares!

NASDAQ Biotech Top Performers (Pre-Open September 19)

Why VIVUS, Inc. Is Today's Best Biotech Stock

VIVUS stock is among today's top gainers after announcing the supplemental new drug approval for erectile dysfunction drug Stendra. Find out how this could impact VIVUS and its shareholders moving forward.

5 Things Arena Pharmaceuticals, Inc.'s Management Wants You to Know

Highlights from Arena Pharmaceuticals' conference call with investors.

Belviq And Phentermine Study Awes Some Investors - Should It?

Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away

See More Articles...